Search results
Results From The WOW.Com Content Network
The cause of serotonin toxicity or accumulation is an important factor in determining the course of treatment. Serotonin is catabolized by monoamine oxidase A in the presence of oxygen, so if care is taken to prevent an unsafe spike in body temperature or metabolic acidosis, oxygenation will assist in dispatching the excess serotonin. The same ...
Serotonin (/ ˌ s ɛr ə ˈ t oʊ n ɪ n, ˌ s ɪər ə-/) [6] [7] [8] or 5-hydroxytryptamine (5-HT) is a monoamine neurotransmitter.Its biological function is complex, touching on diverse functions including mood, cognition, reward, learning, memory, and numerous physiological processes such as vomiting and vasoconstriction.
Antidepressants could increase the risk of suicidal thoughts and behavior in people with depression under the age of 25. In 2004, the U.S. Food and Drug Administration along with the Neuro-Psychopharmacologic Advisory Committee and the Anti-Infective Drugs Advisory Committee, concluded that there was a causal link between newer antidepressants and pediatric suicidality. [7]
People affected by anxiety and depression are believed (at least in part) to have altered levels of serotonin. SSRIs, which first came onto the market in the 1980s, work by blocking the ...
The combination of dopamine, serotonin and oxytocin is already pretty dreamy, but the brain takes that natural high to the next level when you reach the big O by releasing endogenous (i.e., made ...
An addictive personality refers to a hypothesized set of personality traits that make an individual predisposed to developing addictions.This hypothesis states that there may be common personality traits observable in people suffering from addiction; however, the lack of a universally agreed upon definition has marked the research surrounding addictive personality.
Recent research investigating MDMA has revealed the neurotoxic effect of the drug on brain serotonin neurons. [1] [3] [6] [7] [8] Long term and potentially permanent changes to serotonergic axons have been noted in animal and primate studies where they were administered doses of MDMA similar to those taken by some human users.
SSRIs inhibit the reuptake of serotonin. As a result, the serotonin stays in the synaptic gap longer than it normally would, and may repeatedly stimulate the receptors of the recipient cell. In the short run, this leads to an increase in signaling across synapses in which serotonin serves as the primary neurotransmitter.